RNLXY · Renalytix plc
$2.00
+0.04 (+2.04%)
At close · Jul 21
Going-concern doubt
— flagged Nov 19, 2024
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred recurring losses and negative cash flows from operations since inception and had an accumulated deficit of $216.5 million as of September 30, 2024. The Company anticipates incurring additional losses until such time, if ever, that it can generate significant sales of kidneyintelX.dkd or KidneyIntelX technology services income.”View the 10-Q filed Nov 19, 2024
Market Cap
$662.41M
Shares
331.21M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.00
Open$2.00
Day$2.00–2.00
52W$1.00–202.50
Avg vol 30d4K
Short int40K · 0.0% float · 4.8d
Short vol59%
Last earningsMay 15, 2024
DataJul 2020–Jul 2026
Filing10-Q · Nov 19
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
filed Nov 19, 2024
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 17.1 · elevated
Equity put/call 0.65
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−94%
below
Price vs 50-day avg
+39%
above
RSI (14)
69
neutral
MACD trend
Positive
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+69%
trailing
6-month return
−53%
trailing
YTD return
−45%
this year
Relative strength
−61%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $35 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.01% of float · ▲ +74.1% MoM · 4.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
52
elevated · 0–100
Fundamentals
Revenue growth
−33%
Y/Y
Gross margin
7%
contracting
EPS growth
+44%
Y/Y
Free cash flow
$-30.1M
Balance sheet
$4.7M
net cash
Quant / Vol
risk profile
Volatility
146%
annualized · 1-yr
Max drawdown
−99%
past year
ATR
3.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−94%
Bearish
Price vs 50-day avg
+39%
Bullish
RSI (14)
69
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $1 › 200d $35 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.01% of float · ▲ +74.1% MoM · 4.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $1
Now $2 · 0%
52-wk high $203
vs 200-day avg -94%
vs 50-day avg +39%
Illustrative technical + ownership context — a signal mix, not investment advice.
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RNLXY | +4.7% | +69.5% | -53.1% | +42.9% | -44.8% |
| SPY | -0.5% | +0.5% | +7.6% | +0.2% | +9.7% |
| vs SPY | +5.2% | +69.0% | -60.6% | +42.7% | -54.5% |